NCT07736105

Brief Summary

This research study is investigating the efficacy and implementation of expiratory muscle strength training (EMST), standard of care dysphagia treatment, and intensive dysphagia treatment in critically ill adults in the acute care setting. Currently, no targeted, effective, and feasible dysphagia treatment approaches currently exist for use in critically ill adults in the acute care setting. The current study will investigate the impact of EMST, standard of care dysphagia treatment, and intensive dysphagia treatment on pulmonary function, cough function, swallow function, frailty, patient-reported swallow function, and health outcomes in critically ill adults. This study will also examine patient perceptions and clinical speech-language pathologists' perceptions of the acceptability, appropriateness, and feasibility of these interventions. Critically ill adults will: undergo tests of breathing, cough, and swallow function, complete questionnaires about the treatment, and their swallow function, and complete their respective treatment as prescribed. Clinical speech-language pathologists will complete questionnaires about the interventions. A subset of critically ill adults and clinical speech-language pathologists will also have the opportunity to participate in focus groups.

Trial Health

63
Monitor

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
120

participants targeted

Target at P50-P75 for not_applicable

Timeline
22mo left

Started Apr 2027

Typical duration for not_applicable

Geographic Reach
1 country

1 active site

Status
not yet recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

July 22, 2026

Completed
8 days until next milestone

First Posted

Study publicly available on registry

July 30, 2026

Completed
8 months until next milestone

Study Start

First participant enrolled

April 1, 2027

Expected
1.5 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

October 1, 2028

4 months until next milestone

Study Completion

Last participant's last visit for all outcomes

February 1, 2029

Last Updated

July 30, 2026

Status Verified

July 1, 2026

Enrollment Period

1.5 years

First QC Date

July 22, 2026

Last Update Submit

July 29, 2026

Conditions

Keywords

DysphagiaSwallowingDeglutitionDeglutition DisordersSwallowing DisordersBreathingCoughCritical IllnessTreatment

Outcome Measures

Primary Outcomes (2)

  • Change in Dynamic Imaging Grade of Swallowing Toxicity Scale (DIGEST) Grades

    The DIGEST is a validated, 5-point ordinal rating scale that quantifies global pharyngeal swallow function.

    pre-treatment (baseline), and post-treatment prior to hospital discharge, assessed up to 2 weeks

  • Change in Penetration Aspiration Scale Scores

    The penetration aspiration scale is a validated 8-point ordinal rating scale that measures the depth of airway invasion and the patient's response during swallowing. Scores range from 1 to 8 with a score of 1 indicating a safe swallow (best score) and 8 indicating silent aspiration (worst score).

    pre-treatment (baseline), and post-treatment prior to hospital discharge, assessed up to 2 weeks

Secondary Outcomes (9)

  • Change in maximum expiratory pressure

    pre-treatment (baseline), and post-treatment prior to hospital discharge, assessed up to 2 weeks

  • Change in cough peak expiratory flow

    pre-treatment (baseline), and post-treatment prior to hospital discharge, assessed up to 2 weeks

  • Grip strength

    pre-treatment (baseline), and post-treatment prior to hospital discharge, assessed up to 2 weeks

  • Change in Swallowing and Eating Related Fatigue Questionnaire (SERF)

    pre-treatment (baseline), and post-treatment prior to hospital discharge, assessed up to 2 weeks

  • Change in Screening for Oral Frailty Tool (SOFT)

    pre-treatment (baseline), and post-treatment prior to hospital discharge, assessed up to 2 weeks

  • +4 more secondary outcomes

Study Arms (3)

Expiratory muscle strength training (EMST)

EXPERIMENTAL

Critically ill adults will complete EMST as prescribed.

Behavioral: Expiratory muscle strength training (EMST)

Standard of Care Dysphagia Treatment

ACTIVE COMPARATOR

Critically ill adults will receive dysphagia treatment per standard of care.

Behavioral: Standard of Care Dysphagia Treatment

Intensive Dysphagia Treatment

EXPERIMENTAL

Critically ill adults will complete intensive dysphagia treatment as prescribed.

Behavioral: Intensive Dysphagia Treatment

Interventions

EMST devices will be set to 60% of participants' maximum expiratory pressure. Participants will complete training 5 days per week by performing 5 sets of 5 repetitions.

Expiratory muscle strength training (EMST)

Critically ill adults will perform one set of ten repetitions of each exercise recommended by their clinical speech-language pathologist. Enrolled participants will complete up to two training sessions per week (0-2 pending normal clinical care course) with a clinical speech-language pathologist

Standard of Care Dysphagia Treatment

Critically ill adults will perform one set of ten repetitions of each exercise (effortful swallow, Masako maneuver, Mendelsohn maneuver, chin tuck against resistance, tongue strengthening exercises, and may also participate in bolus driven therapy). Enrolled participants will complete five training sessions per week (at least 3 days/week with the PI or a trained member of the research team and up to 2 days/week with a member of the clinical speech-language pathology team).

Intensive Dysphagia Treatment

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Adult ≥ 18 years old
  • Not pregnant
  • Underwent a clinical flexible endoscopic evaluation of swallowing (FEES) or videofluoroscopy swallow study (VFSS) with a penetration aspiration scale (PAS) score ≥ 5
  • Hospitalized in non-neuro intensive care unit (ICU) setting at Vanderbilt University Medical Center (VUMC) at some point during admission
  • Dysphagia is primarily related to ICU stay and not other medical conditions that may cause dysphagia
  • medically cleared with no contraindications for expiratory muscle strength training (EMST) or other treatments
  • Cognitive capacity to follow basic directions
  • Willing to undergo testing and treatment for the study.
  • Adult acute care speech-language pathologist who works at VUMC.
  • Willing to complete surveys and/or participate in a focus group.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Vanderbilt University Medical Center

Nashville, Tennessee, 37232, United States

Location

MeSH Terms

Conditions

Deglutition DisordersCritical IllnessRespiratory AspirationCough

Condition Hierarchy (Ancestors)

Esophageal DiseasesGastrointestinal DiseasesDigestive System DiseasesPharyngeal DiseasesOtorhinolaryngologic DiseasesDisease AttributesPathologic ProcessesPathological Conditions, Signs and SymptomsRespiration DisordersRespiratory Tract DiseasesSigns and Symptoms, RespiratorySigns and Symptoms

Study Officials

  • Cara Donohue, PhD CCC-SLP

    Vanderbilt University Medical Center

    PRINCIPAL INVESTIGATOR

Central Study Contacts

Cara Donohue, PhD CCC-SLP

CONTACT

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
NONE
Purpose
TREATMENT
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Assistant Professor, Director of Medical Speech-Language Pathology

Study Record Dates

First Submitted

July 22, 2026

First Posted

July 30, 2026

Study Start (Estimated)

April 1, 2027

Primary Completion (Estimated)

October 1, 2028

Study Completion (Estimated)

February 1, 2029

Last Updated

July 30, 2026

Record last verified: 2026-07

Data Sharing

IPD Sharing
Will not share

Locations